S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:LIVN

LivaNova - LIVN Stock Forecast, Price & News

$55.68
+0.89 (+1.62%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$54.16
$55.77
50-Day Range
$53.61
$58.14
52-Week Range
$41.82
$88.00
Volume
409,787 shs
Average Volume
459,483 shs
Market Capitalization
$2.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$79.50

LivaNova MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
42.8% Upside
$79.50 Price Target
Short Interest
Bearish
4.05% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$121,123 Sold Last Quarter
Proj. Earnings Growth
42.20%
From $1.73 to $2.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

Medical Sector

362nd out of 1,029 stocks

Electromedical Equipment Industry

9th out of 23 stocks

LIVN stock logo

About LivaNova (NASDAQ:LIVN) Stock

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiovascular and Neuromodulation segments. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and circulatory support products. The Neuromodulation segment designs, develops, and markets Neuromodulation therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression (DTD), and obstructive sleep apnea. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
LivaNova Reports Third-Quarter 2022 Results
Breakeven Is Near for LivaNova PLC (NASDAQ:LIVN)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
LivaNova Enters Oversold Territory (LIVN)
See More Headlines
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

LIVN Company Calendar

Last Earnings
11/03/2021
Today
2/07/2023
Next Earnings (Confirmed)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LIVN
Employees
3,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$79.50
High Stock Price Forecast
$96.00
Low Stock Price Forecast
$62.00
Forecasted Upside/Downside
+42.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-135,820,000.00
Pretax Margin
-8.24%

Debt

Sales & Book Value

Annual Sales
$1.04 billion
Cash Flow
$3.44 per share
Book Value
$24.32 per share

Miscellaneous

Free Float
53,320,000
Market Cap
$2.98 billion
Optionable
Optionable
Beta
0.82

Key Executives

  • Damien McDonaldDamien McDonald
    Chief Executive Officer & Executive Director
  • Stephanie Bolton
    President-International
  • Alex Shvartsburg
    Chief Financial Officer
  • Keyna P. Skeffington
    Secretary, Senior Vice President & General Counsel
  • Michael David Hutchinson
    Chief Legal Officer & Senior Vice President













LIVN Stock - Frequently Asked Questions

Should I buy or sell LivaNova stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LIVN shares.
View LIVN analyst ratings
or view top-rated stocks.

What is LivaNova's stock price forecast for 2023?

5 Wall Street analysts have issued 12-month target prices for LivaNova's stock. Their LIVN share price forecasts range from $62.00 to $96.00. On average, they expect the company's share price to reach $79.50 in the next year. This suggests a possible upside of 44.2% from the stock's current price.
View analysts price targets for LIVN
or view top-rated stocks among Wall Street analysts.

How have LIVN shares performed in 2023?

LivaNova's stock was trading at $55.54 at the beginning of the year. Since then, LIVN stock has decreased by 0.7% and is now trading at $55.14.
View the best growth stocks for 2023 here
.

When is LivaNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our LIVN earnings forecast
.

How can I listen to LivaNova's earnings call?

LivaNova will be holding an earnings conference call on Wednesday, February 22nd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) released its quarterly earnings data on Wednesday, November, 3rd. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.23. The company earned $253.20 million during the quarter, compared to analysts' expectations of $245.24 million. LivaNova had a positive trailing twelve-month return on equity of 9.28% and a negative net margin of 9.14%. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS.

What guidance has LivaNova issued on next quarter's earnings?

LivaNova updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of $2.25-$2.45 for the period, compared to the consensus EPS estimate of $2.30. The company issued revenue guidance of $1.08 billion-$1.10 billion, compared to the consensus revenue estimate of $1.01 billion.

What is Damien McDonald's approval rating as LivaNova's CEO?

47 employees have rated LivaNova Chief Executive Officer Damien McDonald on Glassdoor.com. Damien McDonald has an approval rating of 77% among the company's employees.

What other stocks do shareholders of LivaNova own?
What is LivaNova's stock symbol?

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

Who are LivaNova's major shareholders?

LivaNova's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (1.64%), Allspring Global Investments Holdings LLC (1.46%), Retirement Systems of Alabama (0.35%), Bank of Montreal Can (0.27%), Comerica Bank (0.12%) and New York State Teachers Retirement System (0.12%). Insiders that own company stock include Alfred J Novak, Damien Mcdonald, Daniel Jeffrey Moore and Marco Dolci.
View institutional ownership trends
.

How do I buy shares of LivaNova?

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LivaNova's stock price today?

One share of LIVN stock can currently be purchased for approximately $55.14.

How much money does LivaNova make?

LivaNova (NASDAQ:LIVN) has a market capitalization of $2.95 billion and generates $1.04 billion in revenue each year. The company earns $-135,820,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis.

How many employees does LivaNova have?

The company employs 3,000 workers across the globe.

How can I contact LivaNova?

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The official website for the company is www.livanova.com. The company can be reached via phone at 442033250660, via email at investor.relations@livanova.com, or via fax at 281-218-9332.

This page (NASDAQ:LIVN) was last updated on 2/7/2023 by MarketBeat.com Staff